Medical device firm Stratpharma has appointed Michael Flowers as president of North America commercial operations, the company said Tuesday.
Flowers, whose appointment became effective on April 25, joins the U.S. subsidiary of Swiss-based Stratpharma AG.
He has more than 20 years of commercial leadership experience for North America, most recently having served as chief commercial officer at consultancy WSI. Flowers has also held senior roles at Walgreens, Biogen, Sunovion, UCB and Abbott Laboratories.
